415 related articles for article (PubMed ID: 34654965)
1. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study.
Gu J; Tong T; He C; Xu M; Yang X; Tian J; Jiang T; Wang K
Eur Radiol; 2022 Mar; 32(3):2099-2109. PubMed ID: 34654965
[TBL] [Abstract][Full Text] [Related]
2. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
[TBL] [Abstract][Full Text] [Related]
4. Development of MRI-Based Deep Learning Signature for Prediction of Axillary Response After NAC in Breast Cancer.
Zhang B; Yu Y; Mao Y; Wang H; Lv M; Su X; Wang Y; Li Z; Zhang Z; Bian T; Wang Q
Acad Radiol; 2024 Mar; 31(3):800-811. PubMed ID: 37914627
[TBL] [Abstract][Full Text] [Related]
5. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
[TBL] [Abstract][Full Text] [Related]
6. Deep Learning Model Based on Dual-Modal Ultrasound and Molecular Data for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer.
Huang JX; Shi J; Ding SS; Zhang HL; Wang XY; Lin SY; Xu YF; Wei MJ; Liu LZ; Pei XQ
Acad Radiol; 2023 Sep; 30 Suppl 2():S50-S61. PubMed ID: 37270368
[TBL] [Abstract][Full Text] [Related]
7. Deep Learning of Multimodal Ultrasound: Stratifying the Response to Neoadjuvant Chemotherapy in Breast Cancer Before Treatment.
Gu J; Zhong X; Fang C; Lou W; Fu P; Woodruff HC; Wang B; Jiang T; Lambin P
Oncologist; 2024 Feb; 29(2):e187-e197. PubMed ID: 37669223
[TBL] [Abstract][Full Text] [Related]
8. A hierarchical self-attention-guided deep learning framework to predict breast cancer response to chemotherapy using pre-treatment tumor biopsies.
Saednia K; Tran WT; Sadeghi-Naini A
Med Phys; 2023 Dec; 50(12):7852-7864. PubMed ID: 37403567
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive identification of HER2-low-positive status by MRI-based deep learning radiomics predicts the disease-free survival of patients with breast cancer.
Guo Y; Xie X; Tang W; Chen S; Wang M; Fan Y; Lin C; Hu W; Yang J; Xiang J; Jiang K; Wei X; Huang B; Jiang X
Eur Radiol; 2024 Feb; 34(2):899-913. PubMed ID: 37597033
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method.
Qu YH; Zhu HT; Cao K; Li XT; Ye M; Sun YS
Thorac Cancer; 2020 Mar; 11(3):651-658. PubMed ID: 31944571
[TBL] [Abstract][Full Text] [Related]
11. Delta Radiomics Based on Longitudinal Dual-modal Ultrasound Can Early Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
Huang JX; Wu L; Wang XY; Lin SY; Xu YF; Wei MJ; Pei XQ
Acad Radiol; 2024 May; 31(5):1738-1747. PubMed ID: 38057180
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients.
Zhang J; Wu Q; Yin W; Yang L; Xiao B; Wang J; Yao X
BMC Cancer; 2023 May; 23(1):431. PubMed ID: 37173635
[TBL] [Abstract][Full Text] [Related]
13. Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer.
Qi TH; Hian OH; Kumaran AM; Tan TJ; Cong TRY; Su-Xin GL; Lim EH; Ng R; Yeo MCR; Tching FLLW; Zewen Z; Hui CYS; Xin WR; Ooi SKG; Leong LCH; Tan SM; Preetha M; Sim Y; Tan VKM; Yeong J; Yong WF; Cai Y; Nei WL; ;
Breast Cancer Res Treat; 2022 May; 193(1):121-138. PubMed ID: 35262831
[TBL] [Abstract][Full Text] [Related]
14. An integrated deep learning model for the prediction of pathological complete response to neoadjuvant chemotherapy with serial ultrasonography in breast cancer patients: a multicentre, retrospective study.
Wu L; Ye W; Liu Y; Chen D; Wang Y; Cui Y; Li Z; Li P; Li Z; Liu Z; Liu M; Liang C; Yang X; Xie Y; Wang Y
Breast Cancer Res; 2022 Nov; 24(1):81. PubMed ID: 36414984
[TBL] [Abstract][Full Text] [Related]
15. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
Ma M; Gan L; Liu Y; Jiang Y; Xin L; Liu Y; Qin N; Cheng Y; Liu Q; Xu L; Zhang Y; Wang X; Zhang X; Ye J; Wang X
Eur J Radiol; 2022 Jan; 146():110095. PubMed ID: 34890936
[TBL] [Abstract][Full Text] [Related]
16. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.
Sutton EJ; Onishi N; Fehr DA; Dashevsky BZ; Sadinski M; Pinker K; Martinez DF; Brogi E; Braunstein L; Razavi P; El-Tamer M; Sacchini V; Deasy JO; Morris EA; Veeraraghavan H
Breast Cancer Res; 2020 May; 22(1):57. PubMed ID: 32466777
[TBL] [Abstract][Full Text] [Related]
17. ABVS-Based Radiomics for Early Predicting the Efficacy of Neoadjuvant Chemotherapy in Patients with Breast Cancers.
Jiang W; Deng X; Zhu T; Fang J; Li J
Breast Cancer (Dove Med Press); 2023; 15():625-636. PubMed ID: 37600669
[TBL] [Abstract][Full Text] [Related]
18. Automated prediction of the neoadjuvant chemotherapy response in osteosarcoma with deep learning and an MRI-based radiomics nomogram.
Zhong J; Zhang C; Hu Y; Zhang J; Liu Y; Si L; Xing Y; Ding D; Geng J; Jiao Q; Zhang H; Yang G; Yao W
Eur Radiol; 2022 Sep; 32(9):6196-6206. PubMed ID: 35364712
[TBL] [Abstract][Full Text] [Related]
19. Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.
El Adoui M; Drisis S; Benjelloun M
Int J Comput Assist Radiol Surg; 2020 Sep; 15(9):1491-1500. PubMed ID: 32556920
[TBL] [Abstract][Full Text] [Related]
20. Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer.
Li Y; Fan Y; Xu D; Li Y; Zhong Z; Pan H; Huang B; Xie X; Yang Y; Liu B
Front Oncol; 2022; 12():1041142. PubMed ID: 36686755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
